Mirai Bio, Inc.

Mirai Bio is a biotechnology company dedicated to advancing genetic medicines through precise and scalable delivery systems for nucleic acid payloads, particularly in targeting cells beyond the liver. By harnessing a unique in vivo biodistribution dataset and machine learning for lipid nanoparticle optimization, we empower partners to accelerate their development processes and mitigate technical risks in their high-value projects.